Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection
Timothy W. Baba(Dana-Farber Cancer Institute), Vladimír Liška(Harvard University), Regina Hofmann‐Lehmann(Harvard University), Josef Vlasak(Harvard University), Weidong Xu(Harvard University), Seyoum Ayehunie(Harvard University), Lisa A. Cavacini(Beth Israel Deaconess Medical Center), Marshall R. Posner(Beth Israel Deaconess Medical Center), Hermann Katinger, Gabriela Stiegler, Bruce J. Bernacky(The University of Texas MD Anderson Cancer Center), Tahir A. Rizvi(The University of Texas MD Anderson Cancer Center), Russell D. Schmidt(The University of Texas MD Anderson Cancer Center), Lori R. Hill(The University of Texas MD Anderson Cancer Center), Michale E. Keeling(The University of Texas MD Anderson Cancer Center), Yichen Lu(Harvard University), Joel E. Wright(Harvard University), Ting‐Chao Chou(Memorial Sloan Kettering Cancer Center), Ruth M. Ruprecht(Harvard University)
Cited by 857Open Access